1. Home
  2. ALMS vs LSEA Comparison

ALMS vs LSEA Comparison

Compare ALMS & LSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • LSEA
  • Stock Information
  • Founded
  • ALMS 2021
  • LSEA 2013
  • Country
  • ALMS United States
  • LSEA United States
  • Employees
  • ALMS N/A
  • LSEA N/A
  • Industry
  • ALMS
  • LSEA Homebuilding
  • Sector
  • ALMS
  • LSEA Consumer Discretionary
  • Exchange
  • ALMS NYSE
  • LSEA Nasdaq
  • Market Cap
  • ALMS 402.6M
  • LSEA 411.1M
  • IPO Year
  • ALMS 2024
  • LSEA N/A
  • Fundamental
  • Price
  • ALMS $2.86
  • LSEA $11.30
  • Analyst Decision
  • ALMS Strong Buy
  • LSEA Buy
  • Analyst Count
  • ALMS 7
  • LSEA 4
  • Target Price
  • ALMS $24.50
  • LSEA $13.83
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • LSEA 784.2K
  • Earning Date
  • ALMS 08-12-2025
  • LSEA 07-31-2025
  • Dividend Yield
  • ALMS N/A
  • LSEA N/A
  • EPS Growth
  • ALMS N/A
  • LSEA N/A
  • EPS
  • ALMS N/A
  • LSEA 0.26
  • Revenue
  • ALMS $17,389,000.00
  • LSEA $1,567,107,000.00
  • Revenue This Year
  • ALMS N/A
  • LSEA N/A
  • Revenue Next Year
  • ALMS N/A
  • LSEA $2.87
  • P/E Ratio
  • ALMS N/A
  • LSEA $43.10
  • Revenue Growth
  • ALMS N/A
  • LSEA 24.15
  • 52 Week Low
  • ALMS $2.81
  • LSEA $5.41
  • 52 Week High
  • ALMS $13.53
  • LSEA $14.04
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • LSEA 83.03
  • Support Level
  • ALMS N/A
  • LSEA $11.27
  • Resistance Level
  • ALMS N/A
  • LSEA $11.31
  • Average True Range (ATR)
  • ALMS 0.00
  • LSEA 0.02
  • MACD
  • ALMS 0.00
  • LSEA -0.17
  • Stochastic Oscillator
  • ALMS 0.00
  • LSEA 86.67

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About LSEA Landsea Homes Corporation

Landsea Homes Corp is a growth-oriented homebuilder focused on providing High-Performance Homes that deliver energy-efficient living in attractive geographies. It is engaged in the design, construction, marketing and sale of suburban and urban single-family detached and attached homes in Arizona, California, Colorado, Florida, Texas, and Metro New York. While It offers a wide range of housing options, it focuses on entry-level and first-time move-up homes and believes its markets are characterized by attractive long-term housing fundamentals. The company's segments include Arizona, California, Colorado, Florida, Metro New York, and Texas. It derives a majority of its revenue from home sales in Florida.

Share on Social Networks: